Medical and Pharmaceutical Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs Joseph MortonMarch 26, 2026
AI and Autonomy Window-cleaning robot firm Lucid Bots raises USD$20M as demand accelerates Lucid Bots builds and sells its Sherpa drones and Lavo robot to commercial cleaning companies Joseph MortonMarch 26, 2026
Alternative Energy Energy Fuels produces first U.S. terbium oxide as rare earth supply race heats up The company believes it is the first U.S. producer in decades to report such production from primary mineral feedstock Joseph MortonMarch 26, 2026
Crypto/Blockchain MrBeast’s finance push draws scrutiny from Senator Elizabeth Warren Warren did not accuse the company of wrongdoing in her letter Joseph MortonMarch 25, 2026
Gold Rio Tinto backs LCL Resources Ono project with CAD$48M exploration earn-in deal The companies built this agreement after more than a year of collaboration in Papua New Guinea Joseph MortonMarch 25, 2026
Gold Deep Sea Minerals joins race for seabed metals as U.S. expands critical minerals strategy The application comes amid broader policy momentum from Washington Joseph MortonMarch 25, 2026
Uranium X-Energy moves toward IPO as tech giants drive nuclear power demand The company is developing more than 11 gigawatts of new nuclear capacity through partnerships in the United States and United Kingdom Joseph MortonMarch 24, 2026
AI and Autonomy Canada launches CAD$900 million defence strategy to advance quantum and AI capabilities Minister of National Defence David McGuinty announced the funding at the University of Waterloo Joseph MortonMarch 24, 2026
Crypto/Blockchain Ethereum faces scaling, security and AI crossroads in early 2026 Co-founder Vitalik Buterin argued that current scaling approaches do not fully deliver on Ethereum’s original design goals Joseph MortonMarch 24, 2026
Gold Coeur Mining absorbs New Gold, lifts 2026 production guidance and capital returns In November 2025, Coeur acquired all outstanding New Gold shares Joseph MortonMarch 23, 2026